Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive
Public ClinicalTrials.gov record NCT00495469. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Once-Daily Dose-Ranging Study of GSK189075 Versus Placebo In The Treatment of Type 2 Diabetes Mellitus in Treatment-Naïve Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a dose-ranging study to evaluate the efficacy, safety and tolerability of a range of doses of GSK189075 (an SGLT2 inhibitor) compared to placebo, administered over 12 weeks in treatment-naive subjects with type 2 diabetes mellitus
Study identification
- NCT ID
- NCT00495469
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 17, 2007 (Actual)
- Primary completion
- Jun 5, 2008 (Actual)
- Completion
- Jun 5, 2008 (Actual)
- Last update posted
- Oct 30, 2017
2007 – 2008
United States locations
- U.S. sites
- 65
- U.S. states
- 23
- U.S. cities
- 57
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Mesa | Arizona | 85206 | — |
| GSK Investigational Site | Artesia | California | 90701 | — |
| GSK Investigational Site | Buena Park | California | 90620 | — |
| GSK Investigational Site | Fresno | California | 93720 | — |
| GSK Investigational Site | Greenbrae | California | 94904 | — |
| GSK Investigational Site | La Jolla | California | 92037 | — |
| GSK Investigational Site | Norwalk | California | 90650 | — |
| GSK Investigational Site | Petaluma | California | 94954 | — |
| GSK Investigational Site | Sacramento | California | 95823 | — |
| GSK Investigational Site | San Mateo | California | 94401 | — |
| GSK Investigational Site | Santa Ana | California | 92701 | — |
| GSK Investigational Site | Tarzana | California | 91356 | — |
| GSK Investigational Site | Torrance | California | 90505 | — |
| GSK Investigational Site | Deland/Florida | Florida | 32720 | — |
| GSK Investigational Site | Hollywood | Florida | 33023 | — |
| GSK Investigational Site | Jacksonville/Florida | Florida | 32223 | — |
| GSK Investigational Site | Miami | Florida | 33156 | — |
| GSK Investigational Site | Miami | Florida | 33169 | — |
| GSK Investigational Site | Ocoee/Florida | Florida | 34761 | — |
| GSK Investigational Site | Saint Cloud | Florida | 34769 | — |
| GSK Investigational Site | Atlanta | Georgia | 30322 | — |
| GSK Investigational Site | Atlanta | Georgia | 30342 | — |
| GSK Investigational Site | Bloomingdale | Illinois | 60108 | — |
| GSK Investigational Site | Chicago | Illinois | 60616 | — |
| GSK Investigational Site | Oak Brook | Illinois | 60523 | — |
| GSK Investigational Site | South Bend | Indiana | 46614 | — |
| GSK Investigational Site | Lafayette | Louisiana | 70503 | — |
| GSK Investigational Site | Lake Charles | Louisiana | 70601 | — |
| GSK Investigational Site | Oxon Hill | Maryland | 20745 | — |
| GSK Investigational Site | Boston | Massachusetts | 02118 | — |
| GSK Investigational Site | Gulfport | Mississippi | 39501 | — |
| GSK Investigational Site | Jackson | Mississippi | 39202 | — |
| GSK Investigational Site | Kosciusko | Mississippi | 39090 | — |
| GSK Investigational Site | Rolling Fork | Mississippi | 39159 | — |
| GSK Investigational Site | Chesterfield | Missouri | 63017 | — |
| GSK Investigational Site | Saint Louis/Missouri | Missouri | 63118 | — |
| GSK Investigational Site | Henderson | Nevada | 89014 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89016 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89106 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89119 | — |
| GSK Investigational Site | Las Vegas | Nevada | 89128 | — |
| GSK Investigational Site | Clifton | New Jersey | 7011 | — |
| GSK Investigational Site | Albuquerque | New Mexico | 87102 | — |
| GSK Investigational Site | Commack | New York | 11725 | — |
| GSK Investigational Site | Ithaca | New York | 14850 | — |
| GSK Investigational Site | New York | New York | 10032 | — |
| GSK Investigational Site | Asheboro/North Carolina | North Carolina | 27203 | — |
| GSK Investigational Site | Canal Fulton | Ohio | 44614 | — |
| GSK Investigational Site | Bensalem/Pennsylvania | Pennsylvania | 19020 | — |
| GSK Investigational Site | West Chester | Pennsylvania | 19382 | — |
| GSK Investigational Site | Manning | South Carolina | 29102 | — |
| GSK Investigational Site | Simpsonville | South Carolina | 29681 | — |
| GSK Investigational Site | Athens/Tennessee | Tennessee | 37303 | — |
| GSK Investigational Site | Corpus Christi | Texas | 78404 | — |
| GSK Investigational Site | Dallas | Texas | 75230 | — |
| GSK Investigational Site | Dallas | Texas | 75235 | — |
| GSK Investigational Site | Harlingen/Texas | Texas | 78550 | — |
| GSK Investigational Site | Houston | Texas | 77030 | — |
| GSK Investigational Site | Houston | Texas | 77074 | — |
| GSK Investigational Site | Houston | Texas | 77081 | — |
| GSK Investigational Site | Midland | Texas | 79705 | — |
| GSK Investigational Site | San Anonio | Texas | 78221 | — |
| GSK Investigational Site | San Antonio | Texas | 78229 | — |
| GSK Investigational Site | Burke | Virginia | 22015 | — |
| GSK Investigational Site | Bellevue | Washington | 98004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00495469, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 30, 2017 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00495469 live on ClinicalTrials.gov.